| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | AVROBIO, Inc. | AVRO | Grant | Stock Option (Right to Buy) | 17.6k | $1.09 | $19.2k | | 06/06/2023 |
| 06/08/2022 | AVROBIO, Inc. | AVRO | Grant | Stock Option (Right to Buy) | 17.5k | $1.06 | $18.5k | | 06/08/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 6.1k | $0.00 | $0 | | 05/04/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 11.3k | $18.12 | $205.5k | | 05/04/2022 |
| 05/04/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 10.8k | $18.12 | $194.9k | | 05/04/2022 |
| 07/07/2021 | AVROBIO, Inc. | AVRO | Purchase | Common Stock | 4.8k | $8.35 | $40.1k | | 07/07/2021 |
| 06/10/2021 | AVROBIO, Inc. | AVRO | Grant | Stock Option (Right to Buy) | 17.4k | $9.63 | $167.9k | | 06/10/2021 |
| 05/05/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 4k | $0.00 | $0 | | 05/05/2021 |
| 05/05/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 7.6k | $27.91 | $210.7k | | 05/05/2021 |
| 06/04/2020 | AVROBIO, Inc. | AVRO | Grant | Stock Option (Right to Buy) | 14k | $21.91 | $306.7k | | 06/04/2020 |
| 05/14/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 6k | $0.00 | $0 | | 05/14/2020 |
| 05/14/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 12k | $19.40 | $232.8k | | 05/14/2020 |
| 06/11/2019 | AVROBIO, Inc. | AVRO | Grant | Stock Option (Right to Buy) | 9.7k | $13.60 | $131.6k | | 06/11/2019 |
| 05/09/2019 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 9k | $12.82 | $115.4k | | 05/09/2019 |
| 05/09/2019 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 4.5k | $0.00 | $0 | | 05/09/2019 |
| 01/07/2019 | AVROBIO, Inc. | AVRO | Grant | Stock Option (Right to Buy) | 18.7k | $15.78 | $295.8k | | 01/07/2019 |
| 05/10/2018 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to buy) | 6k | $29.15 | $174.9k | | 05/10/2018 |
| 05/10/2018 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 3k | $0.00 | $0 | | 05/10/2018 |
| 03/16/2018 | Revance Therapeutics, Inc. | RVNC | Purchase | Common Stock | 900 | $31.20 | $28.1k | | 03/16/2018 |
| 03/16/2018 | Revance Therapeutics, Inc. | RVNC | Purchase | Common Stock | 2.2k | $31.25 | $70.3k | | 03/16/2018 |
| 05/05/2016 | Revance Therapeutics, Inc. | RVNC | Grant | Stock Option (Right to Buy) | 8k | $16.63 | $133k | | 05/05/2016 |